Oxidative Stress as an Underlying Contributor in the Development of Chronic Complications in Diabetes Mellitus

The high prevalence of diabetes mellitus and its increasing incidence worldwide, coupled with several complications observed in its carriers, have become a public health issue of great relevance. Chronic hyperglycemia is the main feature of such a disease, being considered the responsible for the establishment of micro and macrovascular complications observed in diabetes. Several efforts have been directed in order to better comprehend the pathophysiological mechanisms involved in the course of this endocrine disease. Recently, numerous authors have suggested that excess generation of highly reactive oxygen and nitrogen species is a key component in the development of complications invoked by hyperglycemia. Overproduction and/or insufficient removal of these reactive species result in vascular dysfunction, damage to cellular proteins, membrane lipids and nucleic acids, leading different research groups to search for biomarkers which would be capable of a proper and accurate measurement of the oxidative stress (OS) in diabetic patients, especially in the presence of chronic complications. In the face of this scenario, the present review briefly addresses the role of hyperglycemia in OS, considering basic mechanisms and their effects in diabetes mellitus, describes some of the more commonly used biomarkers of oxidative/nitrosative damage and includes selected examples of studies which evaluated OS biomarkers in patients with diabetes, pointing to the relevance of such biological components in general oxidative stress status of diabetes mellitus carriers.

[1]  S. Moussa OXIDATIVE STRESS IN DIABETES MELLITUS , 2008 .

[2]  W. Dröge Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[3]  H. Sies,et al.  Oxidative stress: oxidants and antioxidants , 1997, Experimental physiology.

[4]  B. Halliwell Oxidants and human disease: some new concepts 1 , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  M. Cassone-Faldetta,et al.  Insulin decreases intracellular oxidative stress in patients with type 2 diabetes mellitus. , 2006, Metabolism: clinical and experimental.

[6]  M. A. D. Silva,et al.  Marcadores de desequilíbrio redox em sangue de pacientes hipertensos de uma comunidade no Nordeste do Brasil , 2011 .

[7]  Sho-ichi Yamagishi,et al.  Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes , 2011, Experimental Gerontology.

[8]  D. Gelain,et al.  Characterization of Blood Oxidative Stress in Type 2 Diabetes Mellitus Patients: Increase in Lipid Peroxidation and SOD Activity , 2012, Oxidative medicine and cellular longevity.

[9]  M. Dharmalingam,et al.  Oxidative Stress in Obesity and Metabolic Syndrome in Asian Indians , 2011 .

[10]  K. Dahl-Jørgensen,et al.  Microvascular and macrovascular complications , 2007 .

[11]  M. S. Benfato,et al.  Markers of redox imbalance in the blood of hypertensive patients of a community in Northeastern Brazil. , 2011, Arquivos brasileiros de cardiologia.

[12]  A. Cerami,et al.  The biochemistry of the complications of diabetes mellitus. , 1981, Annual review of biochemistry.

[13]  V. Núñez,et al.  Propuesta de un constructo para evaluar integralmente el estrés oxidativo , 2004 .

[14]  A. Lee,et al.  Contributions of polyol pathway to oxidative stress in diabetic cataract , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  R. Haynes Diabetic complications , 2009, Journal of general internal medicine.

[16]  H. Jelinek,et al.  Oxidative DNA damage and obesity in type 2 diabetes mellitus. , 2011, European journal of endocrinology.

[17]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[18]  Liegang Liu,et al.  Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. , 2007, Clinical science.

[19]  A. Piwowar,et al.  AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus. , 2007, Diabetes research and clinical practice.

[20]  Joseph L Evans,et al.  Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? , 2003, Diabetes.

[21]  H. Uzun,et al.  Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. , 2011, Clinical and investigative medicine. Medecine clinique et experimentale.

[22]  A. Nicolosi,et al.  Mitochondrial Sources of H2O2 Generation Play a Key Role in Flow-Mediated Dilation in Human Coronary Resistance Arteries , 2003, Circulation research.

[23]  Erno Harzheim,et al.  Perfil de risco cardíaco no diabetes mellitus e na glicemia de jejum alterada , 2004 .

[24]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[25]  A. Ross,et al.  Reactivity of HO2/O−2 Radicals in Aqueous Solution , 1985 .

[26]  E. Wright,et al.  Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia , 2006, International journal of clinical practice.

[27]  H. Utsumi,et al.  Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. , 2003, Journal of the American Society of Nephrology : JASN.

[28]  H. Brismar,et al.  Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. , 2002, Kidney international.

[29]  S. Chung,et al.  Aldose Reductase–Deficient Mice Are Protected From Delayed Motor Nerve Conduction Velocity, Increased c-Jun NH2-Terminal Kinase Activation, Depletion of Reduced Glutathione, Increased Superoxide Accumulation, and DNA Damage , 2006, Diabetes.

[30]  Y. Miyazaki,et al.  Pancreatic B-cell function is altered by oxidative stress induced by acute hyperglycaemia , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[31]  B. Schaan,et al.  [Cardiac risk profile in diabetes mellitus and impaired fasting glucose]. , 2004, Revista de saude publica.

[32]  T. Yoshikawa,et al.  Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications. , 2003, Diabetes care.

[33]  J. Barbosa,et al.  [The role of advanced glycation end-products (AGEs) in the development of vascular diabetic complications]. , 2008, Arquivos brasileiros de endocrinologia e metabologia.

[34]  V. Monnier,et al.  Intervention against the Maillard reaction in vivo. , 2003, Archives of biochemistry and biophysics.

[35]  D. Graves,et al.  Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor. , 2007, American journal of physiology. Cell physiology.

[36]  野島 秀樹 Effect of aerobic exercise training on oxidative stress in patients with type 2 diabetes mellitus , 2007 .

[37]  G. Damante,et al.  Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. , 2000, Diabetes.

[38]  Joseph L Evans,et al.  The molecular basis for oxidative stress-induced insulin resistance. , 2005, Antioxidants & redox signaling.

[39]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[40]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[41]  Júnia Porto Barbosa,et al.  O papel dos produtos finais da glicação avançada (AGEs) no desencadeamento das complicações vasculares do diabetes , 2008 .

[42]  I. Majsterek,et al.  Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy , 2012, Molecular Biology Reports.

[43]  G. King,et al.  The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO‐MCBN, the American Diabetes Association and the German Diabetes Society , 2001, Diabetes/metabolism research and reviews.

[44]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[45]  C. Ionescu-Tirgoviste,et al.  Increase in Total Antioxidant Capacity of Plasma despite High Levels of Oxidative Stress in Uncomplicated Type 2 Diabetes Mellitus , 2012, The Journal of international medical research.

[46]  S. Chakraborty,et al.  Free Radicals and Cardiovascular Diseases: An Update , 2011 .

[47]  Y. Wada,et al.  Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. , 1997, Kidney international.

[48]  K. Griendling,et al.  Serial Review : The Role of Oxidative Stress in Diabetes mellitus Serial Review , 2006 .

[49]  Uk-Prospective-Diabetes-Study-Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[50]  A. Schmidt,et al.  Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. , 1995, The Journal of clinical investigation.

[51]  D. Ziegler,et al.  Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. , 2004, Diabetes care.

[52]  L. Rossetti,et al.  Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. , 2003, The Journal of clinical investigation.

[53]  M. Laakso,et al.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.

[54]  Dean P. Jones Redefining oxidative stress. , 2006, Antioxidants & redox signaling.

[55]  J. Sastre,et al.  Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. , 2002, Diabetes.

[56]  André L. B. S. Barreiros,et al.  Estresse oxidativo: relação entre geração de espécies reativas e defesa do organismo , 2006 .

[57]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[58]  E. Araki,et al.  Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. , 2003, Diabetes.

[59]  M. Dharmalingam,et al.  Oxidative Stress in Type 2 Diabetes with Iron Deficiency in Asian Indians , 2012 .

[60]  Teven,et al.  MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .

[61]  M. Brownlee Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[62]  L. Rabelo,et al.  Redox unbalance: NADPH oxidase as therapeutic target in blood pressure control. , 2010, Arquivos brasileiros de cardiologia.

[63]  T Zima,et al.  Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. , 2002, Physiological research.

[64]  G. Soliman,et al.  Blood lipid peroxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetic patients. , 2008, Singapore medical journal.

[65]  G. King,et al.  Protein kinase C activation and the development of diabetic complications. , 1998, Diabetes.

[66]  A. Ergul,et al.  Oxidative stress and the use of antioxidants in diabetes : Linking basic science to clinical practice , 2015 .

[67]  Ramazan Memişoğulları,et al.  Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with Type 2 diabetes mellitus. , 2004, Journal of diabetes and its complications.

[68]  H. Kaneto,et al.  Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in beta-cell dysfunction , 1999, Diabetologia.

[69]  L. D. Fonseca,et al.  Desbalanço redox: NADPH oxidase como um alvo terapêutico no manejo cardiovascular , 2010 .

[70]  E. Bechara,et al.  SINGLET OXYGEN-MEDIATED PROTEIN OXIDATION: DAMAGE MECHANISMS, DETECTION TECHNIQUES AND BIOLOGICAL IMPLICATIONS. Proteins are potential targets for singlet molecular oxygen ( , 2006 .

[71]  G. King,et al.  Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies , 2003 .

[72]  P. Groop,et al.  In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. , 1999, Diabetes care.

[73]  M. Fowler Microvascular and Macrovascular Complications of Diabetes , 2008, Clinical Diabetes.

[74]  M. Brownlee,et al.  Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. , 1994, The Journal of clinical investigation.

[75]  H Keen,et al.  The Diabetes Control and Complications Trial (DCCT). , 1994, Health trends.

[76]  J. Hothersall,et al.  The use of pholasin as a probe for the determination of plasma total antioxidant capacity. , 2006, Clinical biochemistry.

[77]  Tim Nolan,et al.  International Diabetes Federation. , 2013, Diabetes research and clinical practice.

[78]  A. Ceriello,et al.  Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[79]  B. Sancak,et al.  Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. , 2004, The Tohoku journal of experimental medicine.

[80]  Leqaa A. Moemen,et al.  Oxidative Stress And Apoptosis In Relation To The Progression Of Diabetic Retinopathy In Diabetics , 2012 .

[81]  P. Mascio,et al.  Oxidação de proteínas por oxigênio singlete: mecanismos de dano, estratégias para detecção e implicações biológicas , 2006 .

[82]  B. Schaan O papel da proteína quinase C no desenvolvimento das complicações vasculares do diabetes mellitus , 2003 .

[83]  J. M. Moita Neto,et al.  Parameters of glycemic control and their relationship with zinc concentrations in blood and with superoxide dismutase enzyme activity in type 2 diabetes patients. , 2011, Arquivos brasileiros de endocrinologia e metabologia.

[84]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[85]  D. Giustarini,et al.  Biomarkers of oxidative damage in human disease. , 2006, Clinical chemistry.

[86]  L. Monnier,et al.  Glycemic Variability , 2008, Diabetes Care.